Loss of the Alox5 Gene Impairs Leukemia Stem Cells and Prevents Chronic Myeloid Leukemia

Overview

Journal Nat Genet

Specialty Genetics

Date 2009 Jun 9

PMID 19503090

Citations 132

Authors

Yaoyu Chen

Yiguo Hu

Haojian Zhang

Cong Peng

Shaoguang Li

Affiliations

Soon will be listed here.

Abstract

Targeting of cancer stem cells is believed to be essential for curative therapy of cancers, but supporting evidence is limited. Few selective target genes in cancer stem cells have been identified. Here we identify the arachidonate 5-lipoxygenase (5-LO) gene (Alox5) as a critical regulator for leukemia stem cells (LSCs) in BCR-ABL-induced chronic myeloid leukemia (CML). In the absence of Alox5, BCR-ABL failed to induce CML in mice. This Alox5 deficiency caused impairment of the function of LSCs but not normal hematopoietic stem cells (HSCs) through affecting differentiation, cell division and survival of long-term LSCs (LT-LSCs), consequently causing a depletion of LSCs and a failure of CML development. Treatment of CML mice with a 5-LO inhibitor also impaired the function of LSCs similarly by affecting LT-LSCs, and prolonged survival. These results demonstrate that a specific target gene can be found in cancer stem cells and its inhibition can completely inhibit the function of these stem cells.

Citing Articles

MLL-AF4 upregulates 5-lipoxygenase expression in t(4;11) leukemia cells via the ALOX5 core promoter.

Hyprath M, Molitor M, Schweighofer I, Marschalek R, Steinhilber D Front Pharmacol. 2025; 15:1520507.

PMID: 39877387 PMC: 11772344. DOI: 10.3389/fphar.2024.1520507.

BCAT1 contributes to the development of TKI-resistant CML.

Jiang Y, Zhang D, He X, Chen C, Xie L, Liu L Cell Oncol (Dordr). 2024; .

PMID: 39412615 DOI: 10.1007/s13402-024-01003-y.

The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing.

Patrignani P, Contursi A, Tacconelli S, Steinhilber D Front Pharmacol. 2024; 15:1472396.

PMID: 39268466 PMC: 11390530. DOI: 10.3389/fphar.2024.1472396.

BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph leukemias?.

Cruz-Rodriguez N, Tang H, Bateman B, Tang W, Deininger M Leukemia. 2024; 38(9):1885-1893.

PMID: 39098922 PMC: 11569815. DOI: 10.1038/s41375-024-02365-w.

The role of human 5-Lipoxygenase (5-LO) in carcinogenesis - a question of canonical and non-canonical functions.

Kahnt A, Hafner A, Steinhilber D Oncogene. 2024; 43(18):1319-1327.

PMID: 38575760 PMC: 11065698. DOI: 10.1038/s41388-024-03016-1.

References

Anderson K, Seed T, Plate J, Jajeh A, Meng J, Harris J . Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis. Leuk Res. 1995; 19(11):789-801. DOI: 10.1016/0145-2126(95)00043-7. View

Huntly B, Shigematsu H, Deguchi K, Lee B, Mizuno S, Duclos N . MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell. 2004; 6(6):587-96. DOI: 10.1016/j.ccr.2004.10.015. View

Zhao L, Moos M, Grabner R, Pedrono F, Fan J, Kaiser B . The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med. 2004; 10(9):966-73. DOI: 10.1038/nm1099. View

Taipale J, Beachy P . The Hedgehog and Wnt signalling pathways in cancer. Nature. 2001; 411(6835):349-54. DOI: 10.1038/35077219. View

Singh S, Clarke I, Terasaki M, Bonn V, Hawkins C, Squire J . Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63(18):5821-8. View

Bonnet D, Dick J . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997; 3(7):730-7. DOI: 10.1038/nm0797-730. View

Radich J, Dai H, Mao M, Oehler V, Schelter J, Druker B . Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2006; 103(8):2794-9. PMC: 1413797. DOI: 10.1073/pnas.0510423103. View

Lessard J, Sauvageau G . Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003; 423(6937):255-60. DOI: 10.1038/nature01572. View

Wang J, Dick J . Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005; 15(9):494-501. DOI: 10.1016/j.tcb.2005.07.004. View

10.

Wymann M, Schneiter R . Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008; 9(2):162-76. DOI: 10.1038/nrm2335. View

11.

Li S, Ilaria Jr R, Million R, Daley G, Van Etten R . The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med. 1999; 189(9):1399-412. PMC: 2193055. DOI: 10.1084/jem.189.9.1399. View

12.

Park I, Qian D, Kiel M, Becker M, Pihalja M, Weissman I . Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003; 423(6937):302-5. DOI: 10.1038/nature01587. View

13.

Zhao C, Blum J, Chen A, Kwon H, Jung S, Cook J . Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell. 2007; 12(6):528-41. PMC: 2262869. DOI: 10.1016/j.ccr.2007.11.003. View

14.

Reya T, Morrison S, Clarke M, Weissman I . Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859):105-11. DOI: 10.1038/35102167. View

15.

Yokomizo T, Izumi T, Shimizu T . Leukotriene B4: metabolism and signal transduction. Arch Biochem Biophys. 2001; 385(2):231-41. DOI: 10.1006/abbi.2000.2168. View

16.

Yilmaz O, Valdez R, Theisen B, Guo W, Ferguson D, Wu H . Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 2006; 441(7092):475-82. DOI: 10.1038/nature04703. View

17.

Graham S, Jorgensen H, Allan E, Pearson C, Alcorn M, Richmond L . Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002; 99(1):319-25. DOI: 10.1182/blood.v99.1.319. View

18.

Chen X, Sheller J, Johnson E, Funk C . Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature. 1994; 372(6502):179-82. DOI: 10.1038/372179a0. View

19.

Tornhamre S, Stenke L, Granzelius A, Sjolinder M, Nasman-Glaser B, Roos C . Inverse relationship between myeloid maturation and leukotriene C4 synthase expression in normal and leukemic myelopoiesis-consistent overexpression of the enzyme in myeloid cells from patients with chronic myeloid leukemia. Exp Hematol. 2003; 31(2):122-30. DOI: 10.1016/s0301-472x(02)01026-3. View

20.

Stenke L, Lauren L, Reizenstein P, Lindgren J . Leukotriene production by fresh human bone marrow cells: evidence of altered lipoxygenase activity in chronic myelocytic leukemia. Exp Hematol. 1987; 15(2):203-7. View